Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 5 of 5 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Research Triangle Park |
| |
Company Enzyvant Inc. | Activity: Research and Development | Company Description Enzyvant, a subsidiary of Sumitovant Biopharma, develops regenerative therapeutics for rare diseases such as congenital athymia. | Location Durham |
| |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham |
| |
Company Precise Bio Inc. | Activity: Research and Development | Company Description Precise Bio grows live and vital complicated organs for transplant using 3D bio-printing. | Location Winston-Salem |
| |
Company ProKidney | Activity: Production and Manufacturing | Company Description ProKidney manufactures cell therapy products that use a patient's own cells to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organs. | Location Winston-Salem |